SMAD2 and gastric cancer: In addition, MIR17HG can enhance the expression of mir‐18a and mir‐19a, suppress the expression of Smad2, and upregulate Wnt/β‐Catenin signaling, thereby facilitating the metastasis of gastric cancer cells.54